What does Noven do?
NOVEN specializes in developing innovative pharmaceutical products, particularly in the fields of dermatology and pain management. The company focuses on enhancing patient outcomes through advanced drug delivery systems and unique formulations. By prioritizing research and development, NOVEN aims to address unmet medical needs and improve the quality of life for patients.
- Activities
- Signals
-
ProfitableProfitable € 1.35M
The company reported a positive net result in the latest financial year.
Strong equityStrong equity € 4.81MStrong equity provides a buffer against setbacks.
Low riskLow risk 82.6%Good solvency (> 30%) points to long-term financial stability.
Good liquidityGood liquidity 3.88A healthy current ratio (≥ 1.5): enough current assets to cover short-term debt.
Positive cashflowPositive cashflow € 1.52MPositive operating cash flow in the latest financial year.
Positive EBITDAPositive EBITDA € 39KPositive EBITDA: operating activities are profitable.
Healthy social debtHealthy social debt 9.9%Social debts stay manageable relative to personnel costs.
Financial ratios
|
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2025
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2024
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2023
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2022
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
|---|---|---|---|---|
|
€
1.31M
|
€
1.10M
|
€
881K
|
€
495K
|
|
|
€
39K
|
€
56K
|
€
44K
|
€
14K
|
|
|
€
1.35M
|
€
1.33M
|
€
301K
|
€
2K
|
|
|
€
4.81M
|
€
3.02M
|
€
1.44M
|
€
960K
|
|
|
82.59%
|
64.62%
|
51.49%
|
57.24%
|
|
|
€
953K
|
€
1.64M
|
€
1.35M
|
€
717K
|
|
|
€
402K
|
€
172K
|
€
117K
|
€
478K
|
|
|
16.80
|
12.80
|
9.90
|
8.20
|
Publications 9
All publications- Statuten (Vertaling, Cordinatie, Overige Wijzigingen, ) - Kapitaal - Aandelen - Ontslagen - Benoemingen 17/01/2024
- Maatschappelijke Zetel 27/07/2023
- Maatschappelijke Zetel 27/06/2022
- Kapitaal - Aandelen 06/01/2022
- Maatschappelijke Zetel 02/09/2021
Frequently asked questions
Answers to the most common questions about Noven, based on official government data and the filed annual accounts.
What is the VAT number of Noven?
The VAT number of Noven is BE0607.985.112.
What is the official website of Noven?
The official website of Noven is www.noven.be.
How many employees work at Noven?
In 2025, Noven employed 16.80 full-time equivalents (FTE).
When was Noven established?
Noven was founded in 25-03-2015.
What is the official address of Noven?
The official address of Noven is Coupure 64/D Gent 9000.
What is the legal form of Noven?
The juridical form of Noven is Public limited company (NV/SA).
What is the annual revenue of Noven?
The 2025 accounts of Noven do not report revenue. Smaller companies that file abbreviated accounts are not required to publish it.
What does Noven do?
NOVEN specializes in developing innovative pharmaceutical products, particularly in the fields of dermatology and pain management. The company focuses on enhancing patient outcomes through advanced drug delivery systems and unique formulations. By prioritizing research and development, NOVEN aims to address unmet medical needs and improve the quality of life for patients.
Is Noven a reliable company?
Noven is a registered Rechtspersoon with company number 0607.985.112 and can be verified through the official CBE database.
What is the credit limit of Noven?
The estimated credit limit of Noven is €297,027.
Is Noven still active?
Noven currently has the status "Normal situation" and is active.